HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rachelle Van Asseldonk Selected Research

2- (2- methyl- 4- chlorophenylamino)- 2- imidazoline (CDMI)

2/2021Lessons learned from inadequate implementation planning of team-based chronic disease management: implementation evaluation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rachelle Van Asseldonk Research Topics

Disease

1Chronic Disease (Chronic Diseases)
02/2021
1Confusion (Bewilderment)
02/2021
1Chronic Obstructive Pulmonary Disease (COPD)
02/2021

Drug/Important Bio-Agent (IBA)

12- (2- methyl- 4- chlorophenylamino)- 2- imidazoline (CDMI)IBA
02/2021